BC
Broadwood Capital Portfolio holdings
AUM
$1.53B
1-Year Return
36.91%
This Quarter Return
+27.06%
1 Year Return
+36.91%
3 Year Return
+67.63%
5 Year Return
+132.65%
10 Year Return
+697.91%
AUM
$1.53B
AUM Growth
+$300M
(+24%)
Cap. Flow
+$31.6M
Cap. Flow
% of AUM
2.06%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
13
New
–
Increased
2
Reduced
2
Closed
–
Top Buys
| 1 |
STAAR Surgical
STAA
|
$17.9M |
| 2 |
Olo Inc
OLO
|
$17.8M |
Top Sells
| 1 |
Monster Beverage
MNST
|
$2.52M |
| 2 |
Axon Enterprise
AXON
|
$1.5M |
Sector Composition
| 1 | Industrials | 37.45% |
| 2 | Consumer Staples | 33.69% |
| 3 | Healthcare | 19.99% |
| 4 | Technology | 2.19% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Axon Enterprise
AXON
$58.1B
| $575M | 36.62% |
694,264
-1,811
| -0.3% | -$1.5M |
|
|
2
Monster Beverage
MNST
$61.5B
| $517M | 32.94% |
8,255,428
-40,262
| -0.5% | -$2.52M |
|
|
3
STAAR Surgical
STAA
$1.37B
| $227M | 14.45% |
13,519,491
+1,064,227
| +9% | +$17.9M |
|
4
iShares Russell 2000 ETF
IWM
$67.9B
| $102M | 6.53% |
474,920
| – | – |
|
5
Lineage Cell Therapeutics
LCTX
$283M
| $45M | 2.86% |
49,560,992
| – | – |
|
|
IMDX
6
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$71.3M
| $34.5M | 2.2% |
11,410,100
| – | – |
|
|
7
Olo Inc
OLO
$1.74B
| $33.7M | 2.14% |
3,782,821
+2,000,487
| +112% | +$17.8M |
|
8
Serina Therapeutics
SER
$53.1M
| $525K | 0.03% |
85,219
| – | – |
|
9
American Airlines Group
AAL
$8.54B
| – | – |
0
| – | – |
|
10
Delta Air Lines
DAL
$40.3B
| – | – |
0
| – | – |
|
11
Hanesbrands
HBI
$2.28B
| – | – |
0
| – | – |
|
12
Southwest Airlines
LUV
$16.7B
| – | – |
0
| – | – |
|
13
United Airlines
UAL
$34.9B
| – | – |
0
| – | – |
|